Related Experiment Video
Updated: May 13, 2026

Cholesterol Efflux Assay
Published on: March 6, 2012
Proprotein convertase subtilisin/kexin type 9 potentially influences cholesterol uptake in macrophages and reverse
Li Shen1, Hong-chun Peng, Shannon N Nees
1Department of Cardiology, Second Xiangya Hospital, Central South University, Changsha 410011, PR China.
Abstract:
Proprotein convertase subtilisin/kexin type 9 (PCSK9) promotes the degradation of low-density lipoprotein receptor (LDLRs) molecules expressed on the cell surface. Gene inactivation of PCSK9 reduces the areas of atherosclerotic lesions in mice, and the effect is mainly dependent on LDLRs. Furthermore, a positive relationship between PCSK9 and cholesterol accumulation in the wall of the aorta has been established. However, the mechanism remains unknown. As PCSK9 is mainly expressed in atherosclerotic plaque and in the liver, we hypothesize that PCSK9 might increase oxidized LDL uptake and impair macrophage-mediated reverse cholesterol transport, contributing to the development of atherosclerosis.
Related Concept Videos
Receptor-mediated Endocytosis
Regulation of Nuclear Protein Sorting
Cholesterol: Significance and Regulation
Considering cholesterol and...
Lipid Absorption
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
Lipid Digestion
Protein Import into the Peroxisomes
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...

